Friday, May 30, 2025
No Result
View All Result
  • Media
Support Us
Macdonald-Laurier Institute
  • Home
  • About
    • Who We Are
    • Who Makes MLI Work
    • Tenth Anniversary
  • Experts
    • Experts Directory
    • In Memoriam
  • Issues
    • Domestic Policy
      • Economic Policy
      • Justice
      • Rights and Freedoms
      • Assisted Suicide (MAID)
      • Health Care
      • COVID-19
      • Gender Identity
      • Canada’s Political Tradition
      • AI, Technology and Innovation
      • Media and Telecoms
      • Housing
      • Immigration
      • Agriculture and Agri-Food
      • Competition Policy
    • Energy Policy
      • Energy
      • Environment
    • Foreign Policy
      • Israel-Hamas War
      • Ukraine
      • Taiwan
      • China
      • Europe and Russia
      • Indo-Pacific
      • Middle East and North Africa
      • North America
      • Foreign Interference
      • National Defence
      • National Security
      • Foreign Affairs
    • Indigenous Affairs
  • Projects
    • CNAPS (Center for North American Prosperity and Security)
    • The Promised Land
    • Voices that Inspire: The Macdonald-Laurier Vancouver Speaker Series
    • Dragon at the Door
    • Canada on top of the world
    • Justice Report Card
    • The Great Energy Crisis
    • DisInfoWatch.org
    • Double Trouble
    • Digital Policy & Connectivity
    • Managing Indigenous Prosperity
    • Defending The Marketplace of Ideas
    • Reforming the University
    • Past Projects
      • Canada and the Indo-Pacific Initiative
      • The Transatlantic Program
      • COVID Misery Index
        • Provincial COVID Misery Index
        • Beyond Lockdown
        • COVID and after: A mandate for recovery
      • Speak for Ourselves
      • The Eavesdropping Dragon: Huawei
      • Talkin’ in the Free World with Mariam Memarsadeghi
      • An Intellectual Property Strategy for Canada
      • Munk Senior Fellows
      • A Mandate for Canada
      • Confederation Series
      • Fiscal Reform
      • The Canadian Century project
      • Fixing Canadian health care
      • Internal trade
      • From a mandate for change
      • Size of government in Canada
      • Straight Talk
      • Labour Market Report
      • Leading Economic Indicator
      • Centre for Advancing Canada’s Interests Abroad
      • Indigenous Prosperity at a Crossroads
        • Aboriginal Canada and Natural Resources
  • Events
    • Upcoming Events
    • Past Events
      • MLI Dinners
      • Great Canadian Debates
  • Latest News
  • Inside Policy
  • Libraries
    • Columns
    • Commentary
    • Papers
    • Books
    • Video
  • Home
  • About
    • Who We Are
    • Who Makes MLI Work
    • Tenth Anniversary
  • Experts
    • Experts Directory
    • In Memoriam
  • Issues
    • Domestic Policy
      • Economic Policy
      • Justice
      • Rights and Freedoms
      • Assisted Suicide (MAID)
      • Health Care
      • COVID-19
      • Gender Identity
      • Canada’s Political Tradition
      • AI, Technology and Innovation
      • Media and Telecoms
      • Housing
      • Immigration
      • Agriculture and Agri-Food
      • Competition Policy
    • Energy Policy
      • Energy
      • Environment
    • Foreign Policy
      • Israel-Hamas War
      • Ukraine
      • Taiwan
      • China
      • Europe and Russia
      • Indo-Pacific
      • Middle East and North Africa
      • North America
      • Foreign Interference
      • National Defence
      • National Security
      • Foreign Affairs
    • Indigenous Affairs
  • Projects
    • CNAPS (Center for North American Prosperity and Security)
    • The Promised Land
    • Voices that Inspire: The Macdonald-Laurier Vancouver Speaker Series
    • Dragon at the Door
    • Canada on top of the world
    • Justice Report Card
    • The Great Energy Crisis
    • DisInfoWatch.org
    • Double Trouble
    • Digital Policy & Connectivity
    • Managing Indigenous Prosperity
    • Defending The Marketplace of Ideas
    • Reforming the University
    • Past Projects
      • Canada and the Indo-Pacific Initiative
      • The Transatlantic Program
      • COVID Misery Index
        • Provincial COVID Misery Index
        • Beyond Lockdown
        • COVID and after: A mandate for recovery
      • Speak for Ourselves
      • The Eavesdropping Dragon: Huawei
      • Talkin’ in the Free World with Mariam Memarsadeghi
      • An Intellectual Property Strategy for Canada
      • Munk Senior Fellows
      • A Mandate for Canada
      • Confederation Series
      • Fiscal Reform
      • The Canadian Century project
      • Fixing Canadian health care
      • Internal trade
      • From a mandate for change
      • Size of government in Canada
      • Straight Talk
      • Labour Market Report
      • Leading Economic Indicator
      • Centre for Advancing Canada’s Interests Abroad
      • Indigenous Prosperity at a Crossroads
        • Aboriginal Canada and Natural Resources
  • Events
    • Upcoming Events
    • Past Events
      • MLI Dinners
      • Great Canadian Debates
  • Latest News
  • Inside Policy
  • Libraries
    • Columns
    • Commentary
    • Papers
    • Books
    • Video
No Result
View All Result
Macdonald-Laurier Institute

Spend less on dental care and pharmacare, more on treatments for rare medical disorders: Nigel Rawson and John Adams in the Financial Post

Three million Canadians suffer from rare illnesses. Although drugs exist for some of them, they are often prohibitively expensive

January 4, 2024
in Domestic Policy, Latest News, Columns, Health, John Adams, Nigel Rawson
Reading Time: 5 mins read
A A
Spend less on dental care and pharmacare, more on treatments for rare medical disorders: Nigel Rawson and John Adams in the Financial Post

This article originally appeared in the Financial Post.

By Nigel Rawson and John Adams, January 8, 2024

The federal government is committing tens of billions of tax dollars to two new programs — dental care and pharmacare. In our view, a persuasive argument can be made that the money would do more good if more of it were directed to Canadians with rare disorders.

A good rule-of-thumb in Ottawa is that budget estimates always underestimate what things will eventually cost. That said, the government’s current plan is to spend $13 billion over five years and $4.4 billion every year after that for a national dental care plan for low- and middle-income Canadians who lack private insurance. It also plans to implement basic pharmacare for Canadians who don’t have private or public drug coverage. Although the new program will only provide coverage for so-called “essential drugs,” such as anti-hypertensives, antibiotics and pain relievers, which generally cost less than a dollar a pill, the government’s own advisory council estimated that pharmacare would cost $15 billion annually.

The Liberals are establishing both programs in order to keep the parliamentary support of the NDP and stay in power in the short term. The two parties apparently believe widely targeted programs will produce the most policy and political mileage for them.

Maybe so, but in terms of policy results at least, $20 billion a year, or some part of it, could bring life-changing, even life-saving benefits to the three million Canadians who currently suffer from rare health disorders. Getting a diagnosis can take years and require expensive travel to major health centres. And of course diagnosis is only the first step in effective care. Although only a tiny fraction of 11,000 known rare diseases are treatable beyond symptoms and palliative care, drugs that have been developed in recent years or are in the pipeline do allow a growing proportion of patients with rare disorders to be helped.

But these drugs are often very expensive, costing hundreds of thousands of dollars per patient per year — even millions for some life-changing, one-course-of-treatment drugs. Such costs are beyond the means of all but the wealthiest among us. Anyone lacking access to the platinum-level private drug insurance that federal politicians and officials enjoy must look to public drug plans to pay for these new drugs.

But governments have created obstacles developers have to clear to get new medicines listed in these public drug plans. They include: an absence of incentives to submit new drugs to Health Canada; health-technology assessments that take a narrow view of benefit, lack accountability and transparency and usually miss deadlines; and slow price negotiations between governments and companies.

Even when developers do make it over these barriers, government gatekeepers slow-walk drugs for rare disorders when putting them on provincial formularies. Process comes before patients. Too often, patients and their doctors wait while every “t” is crossed and “I” dotted at each and every gatekeeping step.

As a result, developers usually bring new medicines to Canada only after introducing them in the United States and Europe. Three of 10 “orphan drugs” don’t make it to Canada at all. Those that are launched face all-too-common delays — even medicines to treat diseases where patients don’t have time to wait, such as cancer, ALS, spinal muscular atrophy and sickle cell disease. So-called universal pharmacare that covers only inexpensive “essential” drugs will be of no help to Canadians with these diseases.

The Liberals’ plan for dealing with the high cost of drugs for rare disorders? Regulate prices down. More radical aspects of their price-control plans have been halted by the courts but they are bound to try other means to reduce the prices of innovative medicines. The likely result is that developers will bring new drugs to Canada last, if at all.

New Zealand provides a cautionary tale. As a result of its severe pricing restrictions, only seven per cent of 460 public-funded medicines introduced in OECD countries in the last 10 years are accessible through its public drug plan. Countries like Estonia, Hungary, Poland and Turkey are ahead of New Zealand in public access to new medicines.

To be sure, the federal government is providing $1.5 billion over three years to increase access to and affordability of effective drugs for rare disorders. Unfortunately, that’s not nearly enough. Cystic fibrosis, the rare genetic disease that leads to a loss of lung function causing much suffering and premature death, affects about 4,000 Canadians. A drug called Trikafta, which has a list price of around $300,000 per year, would help almost all Canadians suffering from it. Even if Trikafta’s price were discounted by 30 per cent for government drug plans, the $500 million Ottawa’s new initiative provides annually would pay for only about 60 per cent of cystic fibrosis sufferers — leaving nothing for other patients and drugs.

These new funds for access to drugs for rare disorders are a step in the right direction. But in a $500-billion-a-year federal budget, $500 million a year is a rounding error. The lives of Canadians with these illnesses should have the same value as everyone else’s, even if their drugs are expensive. Budgetary decisions are tough, yes, but rarely as tough as what faces Canadians with rare disorders, who should not be left to suffer and die because of political minuets in a minority parliament.

Nigel Rawson and John Adams are senior fellows at the Macdonald-Laurier Institute. Adams is also co-founder and CEO of Canadian PKU and Allied Disorders Inc. and volunteer board chair of Best Medicines Coalition.

Source: Financial Post
Previous Post

Russia & Ukraine swap hundreds of prisoners: Christian Leuprecht on CTV News

Next Post

Axe the carbon tax, OK, but keep paying the rebates: Jack Mintz in the Financial Post

Related Posts

Professor Janet Ajzenstat, restoring Canada’s founding principles: David Livingstone for Inside Policy
In Memoriam

Professor Janet Ajzenstat, restoring Canada’s founding principles: David Livingstone for Inside Policy

May 30, 2025
Here’s what the future of Canada’s North should look like: Douglas Lauvstad and Sheila North in Canadian Affairs
Indigenous Affairs

Here’s what the future of Canada’s North should look like: Douglas Lauvstad and Sheila North in Canadian Affairs

May 30, 2025
Land acknowledgements without accompanying actions are hollow gestures: Karen Restoule in The Hub
Indigenous Affairs

Land acknowledgements without accompanying actions are hollow gestures: Karen Restoule in The Hub

May 30, 2025
Next Post
Conservatism is the new counterculture, Liberals are ‘the man’: Jamil Jivani in the National Post

Axe the carbon tax, OK, but keep paying the rebates: Jack Mintz in the Financial Post

Newsletter Signup

  Thank you for Signing Up
  Please correct the marked field(s) below.
Email Address  *
1,true,6,Contact Email,2
First Name *
1,true,1,First Name,2
Last Name *
1,true,1,Last Name,2
*
*Required Fields

Follow us on

Macdonald-Laurier Institute

323 Chapel Street, Suite #300
Ottawa, Ontario, K1N 7Z2 Canada

613.482.8327

info@macdonaldlaurier.ca
MLI directory

Support Us

Support the Macdonald-Laurier Institute to help ensure that Canada is one of the best governed countries in the world. Click below to learn more or become a sponsor.

Support Us

  • Inside Policy Magazine
  • Annual Reports
  • Jobs
  • Privacy Policy

© 2023 Macdonald-Laurier Institute. All Rights reserved.

No Result
View All Result
  • Home
  • About
    • Who We Are
    • Who Makes MLI Work
    • Tenth Anniversary
  • Experts
    • Experts Directory
    • In Memoriam
  • Issues
    • Domestic Policy
      • Economic Policy
      • Justice
      • Rights and Freedoms
      • Assisted Suicide (MAID)
      • Health Care
      • COVID-19
      • Gender Identity
      • Canada’s Political Tradition
      • AI, Technology and Innovation
      • Media and Telecoms
      • Housing
      • Immigration
      • Agriculture and Agri-Food
      • Competition Policy
    • Energy Policy
      • Energy
      • Environment
    • Foreign Policy
      • Israel-Hamas War
      • Ukraine
      • Taiwan
      • China
      • Europe and Russia
      • Indo-Pacific
      • Middle East and North Africa
      • North America
      • Foreign Interference
      • National Defence
      • National Security
      • Foreign Affairs
    • Indigenous Affairs
  • Projects
    • CNAPS (Center for North American Prosperity and Security)
    • The Promised Land
    • Voices that Inspire: The Macdonald-Laurier Vancouver Speaker Series
    • Dragon at the Door
    • Canada on top of the world
    • Justice Report Card
    • The Great Energy Crisis
    • DisInfoWatch.org
    • Double Trouble
    • Digital Policy & Connectivity
    • Managing Indigenous Prosperity
    • Defending The Marketplace of Ideas
    • Reforming the University
    • Past Projects
      • Canada and the Indo-Pacific Initiative
      • The Transatlantic Program
      • COVID Misery Index
      • Speak for Ourselves
      • The Eavesdropping Dragon: Huawei
      • Talkin’ in the Free World with Mariam Memarsadeghi
      • An Intellectual Property Strategy for Canada
      • Munk Senior Fellows
      • A Mandate for Canada
      • Confederation Series
      • Fiscal Reform
      • The Canadian Century project
      • Fixing Canadian health care
      • Internal trade
      • From a mandate for change
      • Size of government in Canada
      • Straight Talk
      • Labour Market Report
      • Leading Economic Indicator
      • Centre for Advancing Canada’s Interests Abroad
      • Indigenous Prosperity at a Crossroads
  • Events
    • Upcoming Events
    • Past Events
      • MLI Dinners
      • Great Canadian Debates
  • Latest News
  • Inside Policy
  • Libraries
    • Columns
    • Commentary
    • Papers
    • Books
    • Video

© 2023 Macdonald-Laurier Institute. All Rights reserved.

Lightbox image placeholder

Previous Slide

Next Slide

Share

Facebook ShareTwitter ShareLinkedin SharePinterest ShareEmail Share

TwitterTwitter
Hide Tweet (admin)

Add this ID to the plugin's Hide Specific Tweets setting: